Low dose oral alpha-interferon therapy for patients seropositive for human immunodeficiency virus type-1 (HIV-1)
View/ Open
Date
1990Author
Koech, D. K
Obel, A. O
Minowada, J
Hutchinson, V. A
Cummins, J. M
Type
ArticleLanguage
enMetadata
Show full item recordAbstract
Thirty eight symptomatic and two asymptomatic patients seropositive for human immunodeficiency virus type-1 (HIV-1) were treated with a natural human interferon alpha (HuIFN alpha). Patients were given 2 IU/kg HuIFN alpha orally once daily in powdered maltose held in the mouth to promote mucosal absorption. This oral immunomodulating HuIFN alpha therapy resulted in an increase in CD4+ lymphocytes, an increase in weight, and a dramatic alleviation of clinical symptoms related to HIV-1 infection.
URI
http://hinari-gw.who.int/whalecomwww.ncbi.nlm.nih.gov/whalecom0/pubmed/1973045http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/31302
Citation
Mol Biother. 1990 Jun;2(2):91-5.Collections
- Faculty of Health Sciences (FHS) [10387]